Change search
ReferencesLink to record
Permanent link

Direct link
Phase 2 open-label extension study of patisiran, an investigational RNAi therapeutic for the treatment of familial amyloid polyneuropathy
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Medicine.
Show others and affiliations
2015 (English)In: Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, E-ISSN 1468-330X, Vol. 86, no 11Article in journal, Meeting abstract (Other academic) PublishedText
Place, publisher, year, edition, pages
2015. Vol. 86, no 11
National Category
URN: urn:nbn:se:umu:diva-112659DOI: 10.1136/jnnp-2015-312379.27ISI: 000364994100028OAI: diva2:881900
Annual Meeting of the Association-of-British-Neurologists (ABN), SEP 10, 2015, Inst Educ, London, ENGLAND
Available from: 2015-12-11 Created: 2015-12-11 Last updated: 2016-01-21Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Suhr, Ole
By organisation
In the same journal
Journal of Neurology, Neurosurgery and Psychiatry

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 75 hits
ReferencesLink to record
Permanent link

Direct link